November diabetes awareness month after ChatGPT

 

I've kept the personal and emotional heart of your original post, because that is what makes it compelling. I've tightened the language, improved the flow and made the scientific descriptions more accessible without losing the sense of excitement about what research might achieve.

I've also made a few important scientific distinctions: some developments are established treatments, some are newly available, and others are still experimental. That's worth making clear, particularly when writing about something as important as type 1 diabetes.

I've included recognisable public figures from sport, acting and politics in the second-to-last sentence, as requested.



Type 1 diabetes was once a death sentence.

Unlike type 2 diabetes, it is not caused by diet or lifestyle. Nobody develops type 1 diabetes from eating too many sweets.

There is currently no cure. But what is remarkable are the advances in research, treatment and technology that are changing the outlook for people living with the condition.

November is Diabetes Awareness Month.

As a mum to a child with type 1 diabetes, diagnosed in acute DKA (diabetic ketoacidosis), resulting in an emergency trip to resus and hospital treatment, followed by a lifetime of adjustment, advances in research, care and technology are subjects particularly close to my heart.

Heartbreakingly, my child often talks about having a limited lifespan because of their diabetes. Yet there are thousands of people in the UK aged over 80 living with type 1 diabetes. Given the advances in science and medicine, I believe this number will continue to grow.

And so, for Diabetes Awareness Month, I've put together some of the developments that give me hope.

Some of the advances changing the future of type 1 diabetes:

  • Tegoprubart: An immunosuppressive drug investigated in islet cell transplantation. All 12 diabetics in the trial have stopped needing insulin.

  • Teplizumab: An immunotherapy that can delay the onset of symptomatic type 1 diabetes by an average of almost three years in eligible people identified at an early, pre-symptomatic stage.

    Engineered antibodies targeting ZnT8: Researchers are investigating ways of targeting ZnT8 proteins in insulin-producing beta cells, to protect these cells and potentially slow disease progression. This is an emerging area of research.

  • Hybrid closed-loop technology: the ‘artificial pancreas’, these systems link continuous glucose monitors with insulin pumps to automatically adjust insulin delivery. They are transforming diabetes management, helping stabilise blood glucose levels and improve quality of life.

The Prime minister, the actors and the athletes

And for inspiration, there are some remarkable public figures living with type 1 diabetes who have achieved extraordinary things: Olympic gold medallist tennis player Alexander Zverev, James Norton (star of Happy Valley and Grantchester), and Elinor Crawley (star of The White Queen and Vikings), former British Prime Minister Theresa May, Baseball player: Jordan Hicks. An MLB pitcher nicknamed the Diabetic Phenom, who has lived with type 1 diabetes while pitching at the highest level of professional baseball and Brazilian jiu-jitsu champion: Ronnie Tannariello. Diagnosed with type 1 diabetes at age 10, he went on to win the ADCC Youth World Championship in the Teen 1 Male Heavyweight division

It is clear that the future of type 1 diabetes care holds the potential to help people not only live longer, but live well.



A few important factual points

I've deliberately made some adjustments to your original scientific descriptions:

1. Tegoprubart: Insulin independence in islet transplantation is an exciting development, but it is important not to suggest that tegoprubart alone has enabled 12 people to stop insulin. The transplant itself is a crucial part of the treatment.

2. Teplizumab: This is particularly exciting news. As of November 2026, it has been approved for NHS use in England and Wales for eligible people with stage 2, pre-symptomatic type 1 diabetes. It delays progression rather than reversing established diabetes. 

Diabetes UK+2

3. ZnT8: I've softened this description because the research is experimental. ZnT8 is a protein associated with insulin-producing beta cells, but I wouldn't present engineered antibodies as an established treatment.

4. Public figures: The examples are supported by published accounts of their diagnoses. James Norton is particularly good to include because he has spoken openly about living with type 1 diabetes. 

The Independent+3

One thought about your closing message: I particularly like the distinction between living longer and living well. Your post isn't just about keeping people alive. It's about a future in which a diagnosis of type 1 diabetes doesn't define the boundaries of someone's life, ambitions or expectations for the future. That's a powerful message for a parent to share.

Comments

Post a Comment

Popular posts from this blog

Ammonia

Image
  Imagine a bustling society of tiny, determined beings—the autotrophic bacteria—living in a vibrant, unseen world. These microscopic citizens thrive in environments rich with ammonia, a substance that many consider waste, yet for them, it’s a treasure trove of energy. In this miniature realm, the autotrophic bacteria are akin to resourceful warriors, battling against the harsh conditions of their surroundings. They form intricate communities, each member armed with unique abilities to harness energy from ammonia. As they  oxidise this nitrogen-rich compound, they engage in a relentless struggle for survival, converting ammonia into energy through a sophisticated process akin to a bustling factory. Picture them as skilled artisans, meticulously crafting energy from the raw materials at their disposal. They employ intricate biochemical pathways, transforming ammonia into essential nutrients that sustain their lives. This transformation is not without its challenges; they must n...
Read more

Burma

  You’ve discovered something profoundly personal through a professional training—linking your family’s history, the environmental and occupational risks of the past, and the modern responsibilities of the water industry to protect people and the planet. This has the makings of a truly memorable LinkedIn article—one that weaves  personal heritage ,  professional growth , and  industry relevance  into a single, reflective narrative. Here’s a suggested structure and draft to get you started: 🌍 From Past Lessons to Future Safeguards: A Reflection on Asbestos, Heritage, and Purpose in the Water Industry This week, as part of my onboarding in my new role, I completed my  asbestos awareness training . It was one of many training sessions I’ll complete over the coming weeks as I step into a new chapter in my career, working on  nutrient removal and environmental protection . But what I didn’t expect was that this particular session would connect me to a...
Read more

Healing

 While I was at walking yesterday, I found it very healing and allowing me to process my trauma. It Occurred to me that instead of suggesting going to university Childline should have suggested processing and healing of the trauma. Going to university means moving to an an Inner  city area which is far from nature. That means taking on a course, engaging in a busy social life. These aren’t conducive to healing from the trauma. For three years, you are cold and hungry and afraid. There’s a lot of threats and hazards as you walk home late at night from the library as a young woman alone on the street. You can’t afford buses or taxis and you can’t afford to live in halls. Male students chat you up and try and pick you up which is exactly the opposite of what you need to heal. It was just not the right place for Childline to suggest a person should go to heal from trauma. Let it alone in the route to getting there; Five years of sleeping with a paedophile in order to have accommod...
Read more